| Catalog No. |
Size |
Price |
Figures |
|---|
Z02027-1 mg
| 1 mg | $ 420.00 |
References:
- Stacey SN, et al. Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA. J. Virol. Aug 2000; 74(16): 7284-7297.
- Stone SF, et al. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. J. Antimicrob. Chemother. Apr 2006; 57(4): 585-588.
|
|---|
| Full Name | | CytomegaloVirus (CMV) Pp150 (UL32) |
|
| Abbreviated Name-1 | CMV Pp150 (UL32) |
|---|
| Description | E. coli derived recombinant. CytomegaloVirus (CMV) Pp150 (UL32) contains the CMV Pp150 (UL32) immunodominant regions. amino acids:(1,011-1,048). CMV-pp150 is purified by proprietary chromatographic techniques. |
|---|
| Source | E. coli |
|---|
| Purity | Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 25 mM Tris-HCl pH 8.0, 1 mM EDTA, 50% glycerol. |
|---|
| Stability | Five years frozen. One month in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of CMV-infected individuals. |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of CMV with minimal specificity problems. |
|---|
